Penick, Emily R.
Bateman, Nicholas W.
Rojas, Christine
Magana, Cuauhtemoc
Conrads, Kelly
Zhou, Ming
Hood, Brian L.
Wang, Guisong
Parikh, Niyati
Huang, Ying
Darcy, Kathleen M.
Casablanca, Yovanni
Mhawech-Fauceglia, Paulette
Conrads, Thomas P.
Maxwell, G. Larry
Funding for this research was provided by:
Uniformed Services University of the Health Sciences (HU0001-16-2-0006)
Article History
Received: 5 May 2022
Accepted: 15 September 2022
First Online: 4 October 2022
Declarations
:
: All study protocols were approved for use under a Western IRB-approved protocol “An Integrated Molecular Analysis of Endometrial and Ovarian Cancer to Identify and Validate Clinically Informative Biomarkers” deemed exempt under US Federal regulation 45 CFR 46.102(f). All experimental protocols involving human data in this study were in accordance with the Declaration of Helsinki.
: Informed consent was obtained from all subjects involved in the study.
: TPC is a ThermoFisher Scientific, Inc SAB member and receives research funding from AbbVie.